| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,016,537 | 689,542 | 655,396 | 741,579 | | Cost of Revenue | 849,941 | 584,515 | 559,083 | 643,461 | | | Gross Profit | 166,596 | 105,027 | 96,313 | 98,118 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 40,104 | 40,088 | 41,251 | 35,651 | | Non Recurring | (1,378) | (77) | 1,455 | 12,180 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 127,870 | 65,016 | 53,607 | 50,287 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (661) |
-
|
-
| | Earnings Before Interest And Taxes | 127,870 | 64,355 | 53,607 | 50,287 | | Interest Expense | 13,724 | 12,209 | 10,456 | 13,945 | | Income Before Tax | 114,146 | 52,146 | 43,151 | 36,342 | | Income Tax Expense | 40,642 | 18,461 | 15,475 | 11,988 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 72,843 | 33,685 | 27,676 | 24,354 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 73,504 | 33,685 | 27,676 | 24,354 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $73,504 | $33,685 | $27,676 | $24,354 |
|
0.51% Nasdaq 
Income Statement
